Bicycle Therapeutics Limited BCYC 深 滬
已收盤 09-05 16:00:00 美东时间
7.16
+0.190
+2.73%
華盛通- 最 高7.23
- 今 開7.06
- 成交量 17.74万股
- 最 低 6.99
- 昨 收 6.97
- 總市值 4.96亿
- 52周最高 28.6701
- 市盈率 靜 --
- 換手率 0.26%
- 52周最低 6.10
- 委 比 -21.68%
- 總股本 6930.65万
- 歷史最高 62.075
- 量 比 0.92
- 振 幅 3.44%
- 歷史最低 6.10
- 每 手 1
- 風險率 6.67%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多4 Analysts Assess Bicycle Therapeutics: What You Need To Know
In the last three months, 4 analysts have published ratings on Bicycle Therapeu...
08-13 03:00
Oppenheimer Maintains Outperform on Bicycle Therapeutics, Lowers Price Target to $44
Oppenheimer analyst Jay Olson maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Outperform and lowers the price target from $48 to $44.
08-11 21:06
Bicycle Therapeutics Appoints Charles Swanton to Board
Bicycle Therapeutics ( ($BCYC) ) has shared an announcement. On August 6, 2025,...
08-08 19:29
Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews
Bicycle Therapeutics (NASDAQ:BCYC) underwent analysis by 7 analysts in the last...
07-18 06:01
RBC Capital Maintains Outperform on Bicycle Therapeutics, Lowers Price Target to $25
RBC Capital analyst Leonid Timashev maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Outperform and lowers the price target from $32 to $25.
07-17 22:07
Is Bicycle Therapeutics (NASDAQ:BCYC) In A Good Position To Invest In Growth?
Even when a business is losing money, it's possible for shareholders to make mo...
07-14 19:29
Bicycle Therapeutics reports Q1 results
Bicycle Therapeutics press release (NASDAQ:BCYC): Q1 GAAP EPS of -$0.88 Revenue of $10M (-48.8% Y/Y). Cash and cash equivalents were $793.0 million as of March 31, 2025, compared to $879.5 million as ...
05-01 22:14
美股大行评级 | 超多美股遭下调评级！高盛：下调美国航空集团评级至"卖出"，目标价从16美元下调至8美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117013356914663424.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持FTC Solar(FTCI)"买入"评级，目标价从1.5美元升至5美元</p> <p>• 摩根士丹利：维持艾伯维(ABBV)"超配"评级，目标价从239美元升至241美
04-10 09:00
Bicycle Therapeutics Announces Key Leadership Changes
The latest announcement is out from Bicycle Therapeutics ( ($BCYC) ). Bicycle T...
03-27 20:28
